NCT05204147 2026-04-22
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
City of Hope Medical Center
Phase 1 Suspended
Clinical Trials
2,030 trialsNCT06979310 2026-04-22
The Comparative Effectiveness Evaluation of the Impact of Digital Education
Duke University
Phase NA Not yet recruiting
NCT07535918 2026-04-22
Using e-Technologies to Maximize Physical Activity After Cancer Treatment
University of Florida
Phase NA Not yet recruiting
NCT02285296 2026-04-21
The Needs and Burden of Family Caregivers of Older Adults With Cancer
University Hospital, Lille
Phase NA Completed
NCT02342158 2026-04-21
PERMED01
Institut Paoli-Calmettes
Phase NA Completed
NCT04637035 2026-04-21
Supportive Oncology Care at Home Post-Discharge
Massachusetts General Hospital
Phase NA Active not recruiting
NCT07485322 2026-04-21
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Inova Health Care Services
Phase NA Not yet recruiting
NCT07541365 2026-04-21
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
Case Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT07543432 2026-04-21
STATIC
Stiftelsen Stockholms Sjukhem
Phase NA Recruiting
NCT02646384 2026-04-20
Ovarian Tissue Cryopreservation in Children
Mayo Clinic
Phase NA Active not recruiting
NCT06731933 2026-04-20
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
Stanford University
Phase 2 Recruiting
NCT07538648 2026-04-20
A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors
Zhejiang Cancer Hospital
Phase 1 Recruiting
NCT07540650 2026-04-20
pRevenT
Institute of Oncology Ljubljana
Phase 2 Not yet recruiting
NCT04452825 2026-04-17
A New Psychotherapy Intervention for Older Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT01187199 2026-04-16
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04879121 2026-04-16
Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07326800 2026-04-16
MAEva-MCT
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT02387905 2026-04-15
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03671226 2026-04-15
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04957615 2026-04-15
Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05347212 2026-04-15
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06669572 2026-04-15
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
University of Chicago
Phase 2 Recruiting
NCT07528547 2026-04-15
Peds Ethos
University Health Network, Toronto
Phase NA Recruiting
NCT01642017 2026-04-14
VOTRAGE
Institut Claudius Regaud
Phase 1 Terminated
NCT02857400 2026-04-14
CREDO
Institut Claudius Regaud
Phase NA Completed
NCT03768336 2026-04-14
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
Phase NA Active not recruiting
NCT03956459 2026-04-14
IQversusMI
Institut Claudius Regaud
Phase NA Completed
NCT05088395 2026-04-14
ALCINA4
Institut Curie
Phase NA Recruiting
NCT05821556 2026-04-14
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
National Cancer Institute, Naples
Phase 2 Recruiting
NCT04520711 2026-04-13
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Providence Health & Services
Phase 1 Active not recruiting
NCT05465161 2026-04-13
StingMark
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Recruiting
NCT05879146 2026-04-13
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06319378 2026-04-13
CAPSI
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2 Recruiting
NCT06609473 2026-04-13
CHEF
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06763770 2026-04-13
Digital Self-Management and Peer Mentoring Intervention
Rutgers, The State University of New Jersey
Phase NA Enrolling by invitation
NCT07515274 2026-04-13
EQUICAP
Centre Leon Berard
Phase NA Not yet recruiting
NCT01706939 2026-04-09
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Phase 3 Active not recruiting
NCT06790602 2026-04-09
SWITCH
University of California, San Diego
Phase 2 Recruiting
NCT07518797 2026-04-09
ASPIRE AI
Rabin Medical Center
Phase NA Not yet recruiting
NCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT07284589 2026-04-08
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT07346209 2026-04-08
STRIPe
University of California, San Diego
Phase 2 Not yet recruiting
NCT07517666 2026-04-08
GIFTT
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT06939452 2026-04-07
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
The First Affiliated Hospital of Zhengzhou University
Phase 2 Active not recruiting
NCT05407844 2026-04-06
DeCIDE PC
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT05784766 2026-04-06
SARIC
University of Oklahoma
Phase NA Active not recruiting
NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
NCT06699615 2026-04-06
Assessing Perceptions of ML Explanations by Medical Oncologists
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT07511023 2026-04-06
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT04309578 2026-04-03
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Phase 2 Completed